StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.90+0.06 (+1.56%)

Close on Nov 17, 2026Market cap $1.37BP/E –Yield –

Nuvation Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Nuvation Bio's price to sales ratio was 8.7× on Nov 11, 2026, against 101.4× a year earlier. Over the last 2 years it ranged from 8.7× to 451.0×, with a median of 69.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.7×−104.4
2025Dec 31, 2025113.2×−300.5
2024Dec 31, 2024413.7×–

More Nuvation Bio figures

See a number that looks wrong?